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Abstract
Background: Molecular diagnostic methods can complement existing tools to improve the diagnosis of malaria. However,
they require good laboratory infrastructure thereby restricting their use to reference laboratories and research studies.
Therefore, adopting molecular tools for routine use in malaria endemic countries will require simpler molecular platforms.
The recently developed loop-mediated isothermal amplification (LAMP) method is relatively simple and can be improved for
better use in endemic countries. In this study, we attempted to improve this method for malaria diagnosis by using a simple
and portable device capable of performing both the amplification and detection (by fluorescence) of LAMP in one platform.
We refer to this as the RealAmp method.
Methodology and Significant Findings: Published genus-specific primers were used to test the utility of this method. DNA
derived from different species of malaria parasites was used for the initial characterization. Clinical samples of P. falciparum
were used to determine the sensitivity and specificity of this system compared to microscopy and a nested PCR method.
Additionally, directly boiled parasite preparations were compared with a conventional DNA isolation method. The RealAmp
method was found to be simple and allowed real-time detection of DNA amplification. The time to amplification varied but
was generally less than 60 minutes. All human-infecting Plasmodium species were detected. The sensitivity and specificity of
RealAmp in detecting P. falciparum was 96.7% and 91.7% respectively, compared to microscopy and 98.9% and 100%
respectively, compared to a standard nested PCR method. In addition, this method consistently detected P. falciparum from
directly boiled blood samples.
Conclusion: This RealAmp method has great potential as a field usable molecular tool for diagnosis of malaria. This tool can
provide an alternative to conventional PCR based diagnostic methods for field use in clinical and operational programs.
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Introduction
Approximately 2 billion people are exposed to malaria with
morbidity surpassing 250 million cases and close to 1 million
deaths per year [1]. Accurate diagnosis is critical for the proper
treatment of malaria [2]. The existing tools for the diagnosis of
malaria include microscopy, parasite antigen/enzyme detection
kits (commonly referred to as rapid diagnostic tests (RDTs)) and
molecular tools (reviewed in [3]). Each of these diagnostic tools has
its own advantages and limitations. At present, microscopy and
RDTs remain the only feasible options for malaria detection in
many endemic countries. Microscopic diagnosis is the oldest
method, can provide quantitative data and can identify species
when used appropriately. Lack of infrastructure and training in
most endemic countries has made microscopic diagnosis challeng-
ing which has contributed to recent interest in deploying RDTs
more broadly. The current RDTs detect parasite antigens such as
histidine rich protein (HRP) -2, lactate dehydrogenase (LDH) and
aldolase using immunochromatographic methods. The majority of
the commercial RDTs detect HRP-2 which is expressed only by P.
falciparum but not other species and therefore this test offers specific
diagnosis of falciparum malaria. A limitation of this test is that HRP-
2 can persist in the blood for several days after the parasites are
cleared therefore the assay cannot accurately tell whether someone
has a current or recently treated infection. Another concern about
this test is the recent discovery that up to 40% of P. falciparum
parasites in parts of South America have deleted the HRP-2 gene
(which leads to false negative results) [4]. Most non-HRP-2 based
tests (LDH and aldolase) are commonly pan-species test that allow
for the speciation of P. falciparum and/or non-falciparum species
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nucleic acid-based molecular methods are a potentially good
alternative for malaria diagnosis as they can accurately differen-
tiate all human-infecting Plasmodium species and detect low levels of
parasitemia. PCR-based diagnosis recently helped to identify P.
knowlesi in humans which had been misdiagnosed using micros-
copy [5]. Unfortunately, the current PCR-based methods are
beyond the capacity of most malaria-endemic countries because
they require sophisticated laboratory infrastructure and training
which makes these techniques expensive and technically challeng-
ing to implement in simple clinical laboratories or field settings.
However, as progress is made towards better malaria control and
eventual goal of elimination, more sensitive diagnostic tools will be
required in order to detect asymptomatic low level parasitemia.
Therefore, further efforts are needed to develop next generation
molecular tools for field use with a goal that such tools can
complement, or in some situations, replace the existing molecular
methods for malaria diagnosis and operational programs such as
monitoring and evaluation of control and elimination programs.
The recently developed loop-mediated isothermal amplification
(LAMP) method is a relatively simple and field-adaptable
technique [6]. Parasite DNA is amplified under isothermal
conditions using a polymerase with strand displacement properties
(usually the Bacillus stearothermophilus (Bst) polymerase); therefore,
sophisticated and expensive thermal cyclers are not required. The
amplification of DNA results in the formation of magnesium
pyrophosphate which appears as a precipitate as the reaction
progresses. The appearance of this precipitate is used as a sign of a
positive reaction. In addition, LAMP was shown to amplify DNA
with high efficiency, amplifying a few copies of DNA to 10
9 in less
than 1 hour [6]. Four LAMP primers are used specific to six sites
of the target sequence which makes them highly specific to the
target [6]. The addition of two extra primers, known as loop-
primers, was shown to accelerate the time to product formation
[7], thereby shortening the required reaction time (30 minutes to
1 hr). Given that this method does not require a thermocycler or
sophisticated training, it has the potential to be used as a molecular
diagnostic tool for point-of-care (POC) diagnosis in both
developing and developed countries provided further modifica-
tions are made. Indeed, LAMP has been used for the detection of
several infectious diseases such as Legionella bacteria [8], West Nile
Virus [9], severe acute respiratory syndrome [10], avian influenza
virus [11], and norovirus [12].
Recently, the LAMP method was used for the detection of
malaria parasites using the 18s rRNA gene as the target gene [13–
17]. Poon et al. 2006 [16] reported successful application of
LAMP for malaria diagnosis for the first time. They reported
detecting P. falciparum directly from heat-treated clinical samples in
which they boiled packed red blood cells at 99uC for 10 minutes,
pelleted the cells by centrifugation and used the supernatant in the
LAMP assay. In this study the sensitivity and specificity of LAMP
was reported to be 95% and 99% respectively compared to an in-
house nested PCR. In 2007, Han et al. reported a species specific
LAMP diagnostic method; using clinical samples and a conven-
tional DNA extraction method, they demonstrated sensitivity and
specificity of 98.5% and 94.3% respectively compared to
microscopy and a nested PCR [14]. Detection limits of 10 copies
of the target 18S rRNA genes for P. malariae and P. ovale and 100
copies for P. falciparum and P. vivax were demonstrated [14]. The
Plasmodium-specific and species-specific primers were shown to
require less than 40 minutes for amplification. In another study,
Paris et al. compared the LAMP method with both microscopy
and P. falciparum HRP-2 RDT [13–17]. They found that LAMP
had 100% specificity and 77.6% sensitivity when compared to
HRP-2 RDT and 100% specificity and 73.1% sensitivity when
compared to microscopy. However, in contrast to what was
reported by Poon et al. the sensitivity and specificity of LAMP
compared to a nested PCR based on primers designed by Singh
et al. [18] were shown to be 79.1% and 58.3% respectively when
heat treatment for DNA extraction was used [15]. Chen et al. used
P. vivax primers to detect microscopically positive P. vivax clinical
samples using the LAMP assay [13]. The limit of detection for P.
vivax was shown to be 30 parasites per microliter (p/mL) [13] with
100% specificity and 98.3% sensitivity compared to microscopy.
The utility of the LAMP assay may be limited by the difficulty of
visualization of precipitate especially at lower target DNA
concentrations. Therefore, attempts have been made to use the
intercalating dye SYBR-Green to measure the end reaction using
a UV light [13,15] or conventional real-time PCR fluorescence
readers [19–22]. However, Paris et al. showed that the UV
fluorescence method produced a high rate of false positives and
suggested that this method be abandoned as a LAMP read-out
[15]. Yamamura et al. combined the LAMP method with a
melting curve analysis using the Genopattern Analyzer GP1000
(Yamato Scientific, Tokyo, Japan) [17]. Using clinical samples,
they demonstrated LAMP sensitivity and specificity of 97.8% and
85.7% respectively, as compared to microscopy. However, the use
of sophisticated equipment for diagnostic applications is not
feasible in many field settings due to the lack of appropriate
infrastructure. Therefore, there is a need for a simple field-usable
method that can afford a quicker and objective readout for the
diagnosis of malaria using the LAMP method. Here, we explored
the utility of a simple portable device (tube scanner) in which both
the amplification platform (heating block) and fluorescent
detection unit for end point use (with the ability to acquire real
time data) are combined into a single unit for LAMP assay. We
refer to this method as RealAmp. We demonstrate the utility of
this method for the diagnosis of malaria by using published
Plasmodium genus specific primers and comparing it to microscopy
and a nested PCR method as described by Singh et al [18].
Methods
Ethics Statement
Samples used in this study were obtained from a human clinical
trial conducted in Tanzania to assess the efficacy of anti-malarial
drugs. This study was approved by both the Ifakara Health
Institute and the CDC Institutional Review Board and informed
written consent forms were obtained from each subject.
Description of the portable equipment
The portable fluorescence reader (ESE-Quant Tube Scanner)
used for this study was developed by a commercial manufacturer
(ESE Gmbh, Stockach, Germany, Figure 1A). This device has an
eight tube holder heating block with adjustable temperature settings
and spectral devices to detect amplified product using fluorescence
spectra. This equipment weighs about 2.2 lbs with the dimensions
74 mm6178 mm6188 mm (H6W 6D). The unit is completely
portable and can be operated with a Li-Ion rechargeable power
pack without external power supply. A small LCD (monitor) is
available to display the results (as positive or negative) without the
need of a computer. However, the device can also be used together
with a computer to generate real time amplification plots as the
reaction progresses (as done in this study).
Plasmodium parasites and clinical samples
P. falciparum (3D7) was cultured in our laboratory. The cultures
were synchronized by the sorbitol method to select for the ring
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reproducibly used for quantitation of DNA. A thin smear was
made, stained with Giemsa and the percentage parasitemia
determined. The number of parasites/mL (p/mL) was determined
by counting the total number of RBCs/mL using a coulter counter
and using the percentage parasitemia data: (p/mL = RBCs/mLx
percentage parasitemia). The other three human-infecting Plas-
modium species, P. vivax (SV4), P. malariae (Uganda I), and P. ovale
(Nigeria I) were acquired from infected monkeys or chimpanzees
at the CDC. The parasites/mL data for these species were
obtained by microscopy. To test the limits of detection of
RealAmp, the DNA from these four species was diluted from
40,000 p/mL or 10,000 p/mLt o1p / mL. In addition, P. knowlesi
and seven other primate malaria parasites, P. inui, P. cynomolgi, P.
coatneyi P. fieldi, P. semiovale, P. fragile, P. gonderi were tested. Ninety
four samples confirmed to be P. falciparum positive by microscopy
obtained from a human clinical trial to assess the efficacy of anti-
malarial drugs and 12 samples known to be negative for P.
falciparum (based on microscopy diagnosis) from a previous study
[23] were used to assess the sensitivity and specificity of the
RealAmp assay. Non-malaria infected human DNA was used as a
control.
DNA extraction
DNA was isolated from all the samples using a QIAamp DNA
Mini Kit (QIAGEN, Valencia, CA-(Qiagen method)). The DNA
was aliquoted and stored at 220uC. To determine the utility of the
heat- treated method of DNA extraction in RealAmp cultured P.
falciparum parasites were subjected to the heat- treatment method
as described by Poon et al. [16]. Briefly, freshly cultured 3D7
parasites were adjusted to 50% hematocrit using whole blood. A
starting parasitemia of 40,000 p/mL was prepared from which six
10-fold serial dilutions were prepared to a final parasite
concentration of 0.4 p/mL. Fifty microliters each of these dilutions
were heated on a heat-block at 99uC for 10 minutes. The tubes
were then centrifuged at 13,000rpm for 3 minutes and the
supernatant collected and used in the RealAmp and nested PCR
assays. In parallel, an aliquot of each of these dilutions was also
subjected to the Qiagen method of DNA isolation and also tested
by both RealAmp and nested PCR methods.
Nested PCR
Nested PCR was performed with primers and cycling conditions
as described by Singh et al. [18] with some modifications.
Reactions were performed in 20 mL total volume containing 1X
buffer, 2.5 mM MgCl2, 200 mM dNTPs, 200 nM primers, and
1.25 units of Taq Polymerase (New England Biolabs, Ipswich,
MA). The PCR amplified material was analyzed using gel
electrophoresis (2% gel) to visualize the bands of appropriate size.
RealAmp Method
The RealAmp method was performed using the commercially
available Loopamp DNA amplification kit (Eiken Chemical Co.,
Ltd., Tokyo, Japan) following the manufacturer’s instructions with
the exception of the addition of 0.25 mL per 12.5 mL reaction
volume of a 1:100 diluted SYBR Green (Invitrogen) or by the use
of an in-house reaction buffer. To test the utility of an in-house
reaction buffer, pilot experiments were performed in a 12.5 mL
total volume containing a 2X in-house buffer (40 mM Tris-HCl
pH 8.8, 20 mM KCl, 16 mM MgSO4, 20 mM (NH4)SO4, 0.2%
Tween-20, 0.8M Betaine, 2.8 mM of dNTPs each), 0.25 mLo fa
1:100 dilution SYBR green and 8 units of Bst polymerase (New
England Biolabs, Ipswich, MA). Genus specific primers, as
described by Han et al. [14] were used to amplify the gene
coding for the 18S ribosomal RNA. DNA amplification was
carried out at 63uC for 90 minutes using the ESE-Quant Tube
Scanner (ESE GmbH., Stockach, Germany) which was set to
collect fluorescence signals at 1 minute intervals. A typical real-
time amplification plot obtained using the RealAmp method is
shown in Figure 1B. In the plot, the Y-axis denotes the
fluorescence units in milli-volts (mV) and the X-axis shows the
time in minutes. Amplification of P. falciparum DNA yielded
sigmoid shaped amplification curve while the control tube (no
DNA) had no measurable fluorescence indicated by a flat line in
the plot.
Statistics
The sensitivity and specificity of RealAmp method was
calculated using both microscopy and a nested PCR assay [18]
as reference tests. The percentage specificity and sensitivity were
calculated using the formulae shown below:
Figure 1. Description of the RealAmp method. The ESE-Quant Tube scanner equipped with temperature settings to amplify DNA isothermally
and spectral devices to detect amplified product using fluorescence is shown (A). The tube scanner can hold 8,200 mL PCR tubes and is equipped
with an LCD panel through which positive or negative results can be detected. If the tube scanner is connected to a computer with the appropriate
software, the results are obtained in real-time as shown in B. The fluorescence units are shown on the Y-axis and the time to amplification on the x-
axis. Amplification curves are observed (solid line) in case of a positive sample. No amplification curves (dotted line) indicate a negative sample.
doi:10.1371/journal.pone.0013733.g001
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6100
Specificity = true negatives/(true negatives + false positives)
6100
In addition, 95% Confidence Intervals (95%CI) for both
sensitivity and specificity were calculated.
Results
Detection of different Human-infecting Plasmodium
species
We were able to amplify any of the four species of human
malaria parasites (P. falciparum, P. vivax, P. malariae and P. ovale)
within 20 minutes (Figure 2). The fluorescence peak typically
persisted for about 5 minutes and then declined over time. In
addition, this assay was able to detect P. knowlesi and seven other
primate malaria parasites (P. inui, P. cynomolgi, P. coatneyi P. fieldi, P.
semiovale, P. fragile, P. gonderi (data not shown)). No amplification as
observed with the non-malaria infected human DNA control
(Figure 2).
Limits of detection of Plasmodium genus-specific
RealAmp
The limits of detection of RealAmp were determined using
DNA obtained from P. falciparum, P. vivax, P. ovale and P. malariae.
The DNA was diluted from 40,000 p/mL( P. falciparum) or 10,000
p/mLt o1p / mL. The limits of detection of RealAmp varied
between 1–100 p/mL for the different species (Table 1). This assay
required at least 1–10 p/mL for the detection of P. ovale and P.
malariae. P. vivax was detected consistently at10 p/mL. For the
detection of P. falciparum a minimum of 10–100 p/mLw a s
required (Table 1). The nested PCR detected up to 1 p/mLf o ra l l
the four species (data not shown). The time to amplification varied
between 15–60 minutes. More time to amplification was required
for samples with lower parasite densities although no clear
correlation was observed between time to amplification and
parasite densities.
Sensitivity and specificity of the RealAmp method
Clinical samples, with median parasitemia density of 3,200 p/
mL (range 61–248,950 p/mL), were used to test the utility of this
platform for the diagnosis of field samples. The sensitivity and
specificity of the RealAmp method compared to microscopy and
nested PCR is shown in Table 2. Of the 94 microscopically
positive samples tested, 90 samples were confirmed to be positive
by the nested PCR and 89 positive by RealAmp. Eleven out of the
12 microscopically negative samples were shown to be negative by
the two methods. Overall, the sensitivity and specificity of
RealAmp and nested PCR was similar when compared to
microscopic data (Table 2). The RealAmp method showed
98.9% (95% CI: 93.1–99.9%) sensitivity and 100% (95% CI:
100%) specificity when compared to nested PCR.
Detection of Plasmodium in heat-treated samples using
the RealAmp method
We compared DNA obtained by the standard Qiagen method
of DNA isolation and that obtained by direct heating for their
performance in RealAmp method. As shown in Table 3, the
RealAmp method was able to amplify up to 40p/mLo fP.
falciparum from heat-treated samples and occasionally up to 4 p/mL
whereas, up to 0.4 p/mL were detected when DNA obtained from
Figure 2. Amplification of the four human-infecting Plasmodium species using the RealAmp method. Plasmodium genus-specific
primers were used to amplify the 18s ribosomal RNA gene in P. falciparum, P. vivax, P. malariae and P. ovale parasites. Amplification curves (positive)
were observed for all the four species within 20 minutes (vertical dotted line). No amplification was seen with malaria-free human DNA (Human) or in
the no template control (NTC).
doi:10.1371/journal.pone.0013733.g002
Table 1. Detection limits of the RealAmp method tested
using 10-fold serial dilutions of P. falciparum P. vivax, P. ovale
and P. malariae DNA.
Lowest conc.
detected (p/mL) P. falciparum P. malariae P. ovale P. vivax
Run # 11 0 1 11 0
Run # 2 100 10 1 10
Run # 3 10 Not tested 10 10
Run # 4 100 Not tested Not tested 10
doi:10.1371/journal.pone.0013733.t001
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amplification below 40 p/mL especially with heat treated DNA.
No amplification was detected with heat-treated uninfected whole
blood (data not shown).
Cost analysis of the RealAmp method compared to the
nested PCR
Table 4 summarizes the cost of running the RealAmp method
compared to that for nested PCR assay. The cost of performing
RealAmp was lower when an in-house buffer was used. However,
the cost of RealAmp increased when a commercially available
buffer was used. The capital investment cost for both PCR and
tube scanner was comparable (Table 4). In addition, there are
important practical advantages of using RealAmp as further
discussed.
Discussion
The LAMP molecular assay is a potentially useful alternative to
the current molecular tools that require sophisticated equipment
and techniques [6]. A few studies have clearly demonstrated that
LAMP can be used for malaria diagnosis [13–17]. In this study we
integrated the amplification and detection stages of LAMP into
one portable and simple to use platform in an attempt to make this
method easily usable even in field settings. As summarized in
Table 5, results from the RealAmp method were comparable to
the previously reported malaria LAMP assays [13–17] demon-
strating reasonable sensitivity and specificity profiles when
compared to microscopy and nested PCR. The reported
sensitivities and specificities ranged from 73.1% to 98.3% and
85.7% to 100%, respectively, using microscopy as a reference
standard (Table 5). Two of these studies [15,16] also compared
malaria LAMP assays with PCR-based assays (Table 5) and one
study used HRP-2 RDT as a reference [15]. The use of different
reference tests, such as different PCR-based assays, clearly
influences the sensitivity and specificity profile obtained. In
addition, differences in the parasite densities of the samples used
in the various studies may influence the sensitivities and
specificities which could explain the variations observed across
these studies. Out of the 94 microscopically positive samples used
in this study, 4 were negative by nested PCR and 5 by RealAmp
assay. The parasite density determined by microscopy for these
samples ranged from 240 p/mL to 191,320 p/mL. Failure to
amplify these samples by these two molecular methods was not
due to low parasite density but most likely due to poor quality of
the DNA preparation since we could not amplify some of the same
samples using other nucleic acid tests. Further prospective studies
in different transmission settings will be required to further
evaluate the performance of the RealAmp method in comparison
to other routine diagnostic tests.
One of the limitations of the current study is the fact that the
RealAmp method was evaluated using only Plasmodium genus
specific primers. Although the LAMP method can be used for the
diagnosis of malaria parasites at the species level [14], attempts to
use these published species specific primers did not yield consistent
results in our hands both by conventional LAMP and RealAmp
methods. We are currently evaluating the use of new DNA targets
to develop primer sets that can be used for malaria species
diagnosis. Despite this limitation, this genus-specific RealAmp
method can be used for monitoring and evaluation of malaria
control programs in the field. It can also be used as a confirmatory
test for malaria infection in place of a standard PCR-based assay.
The observation that the lowest level of parasitemia required to
detect P. falciparum was one to two orders of magnitude higher than
that needed for the other three species tested can be explained by
the fact that the P. falciparum samples used were selected for the
ring stages whereas all parasite stages (rings and schizonts, the
latter containing more DNA than the ring stage) were present in
the other Plasmodium species. These limits of detection with this
genus-specific RealAmp method are similar or better than those
reported for microscopy and RDTs. Improving on the limits of
detection by RealAmp (or any other malaria diagnostic test) has
real potential now more than ever as there is a concerted effort to
increase malaria prevention and control programs. It is hoped that
these programs will lead to a reduction in malaria transmission
Table 2. Sensitivity and Specificity of the RealAmp method
and nested PCR compared to microscopy.
Microscopy
(n) Nested PCR RealAmp
Positive Negative Positive Negative
Positive (94) 90 4 89 5
Negative (12) 1 11 1 11
Sensitivity 95.7% (95% CI: 88.8–98.6%) 96.7% (95% CI: 87.5–93.8%)
Specificity 91.7% (95% CI: 59.8–99.6%) 91.7% (95% CI: 59.8–99.6%)
doi:10.1371/journal.pone.0013733.t002
Table 3. Amplification of Plasmodium falciparum from heat
treated blood samples.
Amount of
parasites (p/mL) Qiagen method
Heat-Treatment
method
Run 1 Run 2 Run 3 Run 1 Run 2 Run 3
40,000 Pos Pos Pos Pos Pos Pos
4,000 Pos Pos Pos Pos Pos Pos
400 Pos Pos Pos Pos Pos Pos
40 Pos Pos Pos Pos Pos Pos
4 ND Pos Pos Pos Pos ND
0.4 Pos Pos Pos ND ND ND
1Three independent experiments (runs) are reported. Pos= positive; ND= not
detected.
doi:10.1371/journal.pone.0013733.t003
Table 4. Cost analysis of the RealAmp method compared to
the nested PCR.
Total USD for
Start- up
Total USD per
sample**
Nested PCR 3,000–8000* 3.67
RealAmp using an
in-house buffer
6, 344
# 2.66
RealAmp using a
commercial buffer
Same as above 5.05
2*Refers to the cost of buying the equipment as listed by various major
suppliers in the USA.
#Refers to price we paid for the equipment which could differ for other users.
**Cost includes all the necessary reagents and consumables; it does not include
personnel cost.
doi:10.1371/journal.pone.0013733.t004
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tools that can be used in field settings will be needed for the
evaluation of these control programs.
The RealAmp method, as reported here, was not designed for
the quantitation of parasitemia. We observed that the time to
amplification was shorter for samples with high parasite densities
than for samples with low parasite densities. However, this
relationship was noticed only when the reactions were run
simultaneously: a strict correlation was not observed when samples
were compared between runs indicating that one cannot draw
conclusions about parasitemia levels based on the amplification
time. Further efforts are needed to determine if this method can be
improved for quantitative purpose.
The use of the heat-treatment method for template preparation
provides a good alternative to the expensive and labor intensive
DNA isolation methods that might not always be possible in field
settings. In this study we were able to successfully use heat-treated
samples for RealAmp amplification similar to results reported by
Poon et al [16]. We did not observe any inhibition of PCR
amplification as, previously reported [16], when using the heat-
treated sample for DNA amplification in the nested PCR assay.
The heat-treatment method yielded DNA extract that could be
used to reliably detect as low as 40 p/mL. At this level of detection
limit, we hope it will yield results that can be comparable to
microscopic diagnosis (100–200 p/mL) in the field. This method
showed slightly lower efficiency compared to Qiagen method
(below 40 p/mL) and it is not clear if this difference was due to
poor efficiency in DNA extraction at low parasitemia level or due
to other factors. Nevertheless, these results clearly illustrate that
the heat-treatment method can be further improved to make it an
alternative to conventional DNA isolation methods in the field.
In our hands, the cost of running the RealAmp method was
cheaper than that of the nested PCR when an in-house buffer was
used in place of the commercially available buffer. The
performance of our in-house buffer was as good as that of the
commercial buffer and it consistently yielded similar results. Our
price estimates are arbitrary and may vary for other users
depending on where and how their reagents and equipment are
purchased. These cost estimates do not include labor and other
infrastructure costs which will vary too, depending on the region.
Regardless of these cost factors, there are several important
practical aspects of the RealAmp that makes it an attractive
method for field use. This includes a) the fact that the tube scanner
is light and small and is easily portable to even remote places while
standard thermocyclers require an established laboratory setting,
b) an alternate power source such as battery can be used to operate
the tube scanner, c) no post-run manipulation such as gel
electrophoresis is required to visualize the results contributing to
shorter turnaround time, d) the RealAmp method is technically
easier to perform than the nested PCR, e) this method has
automation features to report results directly to remote locations,
and f) this method can be modified to handle large sample
numbers (e.g. using a 96-well plate holder).
The tube scanner is comparable to the real-time turbidimeter
used in some studies [16] in the sense that both are capable of
detecting a positive sample in real-time resulting in similar
amplification plots. The tubidimeter measures the turbidity of
reaction mixture while the RealAmp measures the fluorescence
units generated as the product is formed. However, the tube
scanner has an added feature in which the results (as positive (+)o r
negative (2)) can be reported on the provided LCD without the
need of a computer. It would be of interest to compare the utility
of these two readout machines simultaneously to determine if there
is any advantage of using one over the other. We would like to
point out that the RealAmp method can be performed with any
alternative equipment that is similar to the tube scanner used in
the study.
The utility of any diagnostic assay for point-of-care and field use
will lie, among other things, on the fact that it is less expensive and
simple to perform without compromising its sensitivity and
specificity. The RealAmp method will be more attractive for field
use if the LAMP reagents can be stored at room temperature
without requiring a cold chain. Our preliminary data suggests that
the RealAmp reagents can be kept at least for two weeks at room
temperature without loss of activity but further studies are required
to investigate this fully. In summary, this study has shown that the
RealAmp method is a potential field usable tool for diagnostic
purpose and for use in malaria control programs. Further field
studies in different endemic countries will help to optimize its use
for various malaria control applications and as a point-of-care tool.
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Table 5. Summary of sensitivity and specificity of malaria LAMP assays reported in the literature.
Reference test Poon et al. [16] Paris et al. [15] Han et al. [14] Chen et al. [13] Yamamura et al. [17] RealAmp#
Microscopy
(parasitemia)*
Not reported Not reported 210–24,164p/mL Not reported 0.06–6.12% parasitemia 61–248960 p/mL
Sensitivity (%) 73.1 94.3 98.3 97.8 96.7
Specificity (%) 100 98.5 100 85.7 91.7
Nested PCR
Sensitivity (%) 95
** 76.1/79.1
** 98.8
Specificity (%) 99
** 89.6/58.3
** 100
HRP-II RDT
Sensitivity (%) 77.6
Specificity (%) 100
3*As reported by the authors.
**In these studies DNA amplification was performed using heat treated whole blood.
#Results from the current study.
doi:10.1371/journal.pone.0013733.t005
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